Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

Phase 3CompletedNCT04353336

Tanta University194 enrolled

Overview

Chloroquine or hydroxychloroquine in COVID-19 treatment

Clinical Study Evaluating the Efficacy of Chloroquine or hydroxychloroquine in COVID-19 treatment

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

194

Conditions

COVID-19 Coronavirus Infection

Interventions

Chloroquine or HydroxychloroquineDRUG

Chloroquine or Hydroxychloroquine

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Covid 19 patients Exclusion Criteria: * Allergy or contraindication to the drug * Pregnant or lactating * Patients with cardiac problems

Locations (1)

Tanta University, Assiut University

Tanta, Egypt

Outcomes

Primary Outcomes

Number of patients with cure or death

the number of patients with cure or death

Time frame: 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.